H-Tyr-OBzl

H-Tyr-OBzl is a benzyl-protected tyrosine derivative in which the tyrosine side chain phenol remains unprotected while the C-terminal carboxyl group is masked as a benzyl ester (OBzl) and the N-terminus is presented as a free amino group (H-). The molecule therefore combines an aniline-like phenolic aromatic ring with a benzylic ester functionality that can participate in standard amino acid coupling chemistry after activation of the amino group. The stereochemical outcome is governed by the parent L-tyrosine configuration, making H-Tyr-OBzl a chiral amino acid ester suitable for stereochemically defined peptide construction. The benzyl ester can be removed under hydrogenolysis conditions, while the phenolic hydroxyl can be selectively protected or left for post-coupling functionalization, enabling controlled access to tyrosine-derived motifs in synthetic and biochemical workflows.

1. Peptide Synthesis

H-Tyr-OBzl is applied in peptide building block preparation where the free N-terminus supports amide bond formation with activated carboxylic acid partners. The benzyl ester at the C-terminus functions as a removable protecting group that can be retained during iterative peptide coupling steps and later cleaved to reveal the carboxylic acid for subsequent chain extension or final deprotection. The phenolic hydroxyl on the tyrosine side chain can be leveraged for orthogonal protection strategies, allowing selective phenol protection when needed to prevent side reactions during coupling. Downstream, H-Tyr-OBzl can be used to generate tyrosine-containing peptides and peptide fragments with defined C-terminal functionality and controlled phenolic reactivity.

2. Side-Chain Functionalization

H-Tyr-OBzl is suitable for chemical biology and synthetic organic chemistry routes that require controlled manipulation of the tyrosine phenolic group while maintaining an ester-protected carboxyl handle. The phenolic hydroxyl enables derivatization to ether, carbonate, or other protected phenol forms, supporting orthogonal chemistry relative to the benzyl ester cleavage. The benzyl ester can be carried through side-chain modification steps and then removed to furnish a free acid for conjugation, immobilization, or incorporation into larger constructs. Resulting derivatives can serve as intermediates for tyrosine-based post-synthetic modification, peptidomimetic scaffold elaboration, and functional molecule generation where phenol chemistry is a key recognition element.

3. Chiral Amino Acid Intermediate

H-Tyr-OBzl is employed as a chiral amino acid intermediate in stereochemically controlled synthesis of tyrosine-containing frameworks and intermediate peptide-like units. The L-tyrosine-derived stereocenter is preserved through the benzyl ester formation, supporting consistent stereochemical identity during downstream coupling and deprotection sequences. The N-terminal amino group enables installation into amide-linked structures, while the benzyl ester provides a stable C-terminal protecting group for process-compatible handling. After hydrogenolysis to remove the OBzl group, the resulting tyrosine carboxylic acid can be used for further derivatization, chain extension, or conversion into activated forms for manufacturing-scale fine chemical synthesis.

4. Bioconjugation Chemistry

H-Tyr-OBzl can be applied in bioconjugation workflows that require tyrosine-bearing linkers or peptide fragments with a deprotectable C-terminal acid for coupling to biomolecule scaffolds. The benzyl ester masking supports storage and controlled processing prior to conversion into a free carboxyl group suitable for amide formation, esterification, or other carboxyl-directed conjugation chemistries. The unprotected phenolic hydroxyl can be used for selective conjugation strategies or can be temporarily protected to regulate chemoselectivity during biomolecule labeling. Downstream, H-Tyr-OBzl-derived intermediates can support preparation of tyrosine-functional conjugates used in biochemical research, analytical labeling, and molecular probe construction.

5. Pharmaceutical Intermediate Preparation

H-Tyr-OBzl is relevant to pharmaceutical intermediate preparation where protected amino acid esters and tyrosine-containing fragments are used to assemble peptidic or peptidomimetic structures. The combination of an N-terminal amino group for coupling and a benzyl ester for C-terminal protection aligns with common synthetic logic for stepwise assembly and controlled deprotection. Phenolic hydroxyl chemistry can be managed through selective protection when needed to suppress side reactions, while benzyl ester removal enables access to carboxylic acid functionality for subsequent transformations. Resulting tyrosine-containing intermediates can feed into downstream synthesis of larger drug-like molecules, including structurally defined peptide analogs and SAR-focused libraries where stereochemical fidelity and functional-group orchestration are required.

6. Process Chemistry Intermediate

H-Tyr-OBzl is suitable for process chemistry intermediate manufacture due to the stability of the benzyl ester under typical handling conditions and the predictable hydrogenolysis deprotection behavior. The molecule's functional group set, featuring a free amino group and a phenolic hydroxyl, supports controlled protection/deprotection planning to minimize side reactions during scale-up coupling operations. The benzyl-protected carboxyl group can be maintained during intermediate synthesis steps, then removed to regenerate a reactive acid for further conversion or final specification of the product form. Downstream, H-Tyr-OBzl can serve as a reproducible chiral tyrosine building block for industrial fine chemical synthesis, enabling consistent feedstock preparation for peptide construction and amino acid derivative manufacturing.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

5. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines